MHRA Alert – July 2024 Medicine Recalls and Safety Letters

Important Safety Updates from the MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a summary of letters and notifications issued to healthcare professionals during July 2024. These communications cover a range of medicines and medical devices and include safety alerts, recalls, and important clinical guidance.

What You Need to Know

This monthly summary consolidates key safety information distributed by the MHRA to ensure all healthcare professionals remain informed of emerging risks, product recalls, and regulatory actions affecting medicines and devices in current use.

Recommended Actions

• Review the full MHRA alert to identify any products used in your clinical setting
• Check whether any recalled or flagged medicines are in your stock or patient care protocols
• Cascade relevant information to your team, particularly pharmacy and nursing staff
• Report any adverse events or product defects to the MHRA via the Yellow Card scheme

Access the Full Alert

For the complete list of medicines, medical devices, and specific safety recommendations, visit the MHRA drug safety update page.

Published: 21 August 2024